🔎 Trials Near Me

Avaleht › Crohni tõbi › Oklahoma

Crohni tõbi kliinilised uuringud osariigis Oklahoma

8 uuringut haiguse Crohni tõbi jaoks otsivad osalejaid osariigis Oklahoma.

Linnad osariigis Oklahoma

Ametlik uuringutekst (inglise keeles)

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

  • Digestive Disease Specialists Inc. ( Site 5117), Oklahoma City
VärbamineFaas 3
Vanused 16–80 · Kõik sood · Uuendatud 2. okt 2026 · NCT06430801

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

  • Digestive Disease Specialists - Oklahoma /ID# 265901, Oklahoma City
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 25. sept 2026 · NCT06548542

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

  • Digestive Disease Specialists Inc, Oklahoma City
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. sept 2026 · NCT07499232

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

  • Central Sooner Research-Site Number: 8400094, Norman
VärbamineFaas 3
Vanused 16–80 · Kõik sood · Uuendatud 23. sept 2026 · NCT07184931

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

  • Digestive Disease Specialists, Inc., Oklahoma City
VärbamineFaas 4
Vanused 18–70 · Kõik sood · Uuendatud 9. sept 2026 · NCT06045754

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

  • Digestive Disease Specialists Inc, Oklahoma City
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. aug 2026 · NCT07577843

A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

  • The University of Oklahoma Health Sciences Center, Oklahoma City
VärbamineFaas 3
Vanused 2–17 · Kõik sood · Uuendatud 3. aug 2026 · NCT06100289

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • The University of Oklahoma Health Sciences Center, Oklahoma City
VärbamineFaas 3
Vanused 2–17 · Kõik sood · Uuendatud 22. juuni 2026 · NCT06405087

Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.